Literature DB >> 10863066

Modeling normal tissue complication probability from repetitive computed tomography scans during fractionated high-dose-rate brachytherapy and external beam radiotherapy of the uterine cervix.

E Dale1, T P Hellebust, A Skjønsberg, T Høgberg, D R Olsen.   

Abstract

PURPOSE: To calculate the normal tissue complication probability (NTCP) of late radiation effects on the rectum and bladder from repetitive CT scans during fractionated high-dose-rate brachytherapy (HDRB) and external beam radiotherapy (EBRT) of the uterine cervix and compare the NTCP with the clinical frequency of late effects. METHODS AND MATERIALS: Fourteen patients with cancer of the uterine cervix (Stage IIb-IVa) underwent 3-6 (mean, 4.9) CT scans in treatment position during their course of HDRB using a ring applicator with an Iridium stepping source. The rectal and bladder walls were delineated on the treatment-planning system, such that a constant wall volume independent of organ filling was achieved. Dose-volume histograms (DVH) of the rectal and bladder walls were acquired. A method of summing multiple DVHs accounting for variable dose per fraction were applied to the DVHs of HDRB and EBRT together with the Lyman-Kutcher NTCP model fitted to clinical dose-volume tolerance data from recent studies.
RESULTS: The D(mean) of the DVH from EBRT was close to the D(max) for both the rectum and bladder, confirming that the DVH from EBRT corresponded with homogeneous whole-organ irradiation. The NTCP of the rectum was 19.7% (13.5%, 25. 9%) (mean and 95% confidence interval), whereas the clinical frequency of late rectal sequelae (Grade 3-4, RTOG/EORTC) was 13% based on material from 200 patients. For the bladder the NTCP was 61. 9% (46.8%, 76.9%) as compared to the clinical frequency of Grade 3-4 late effects of 14%. If only 1 CT scan from HDRB was assumed available, the relative uncertainty (standard deviation or SD) of the NTCP value for an arbitrary patient was 20-30%, whereas 4 CT scans provided an uncertainty of 12-13%.
CONCLUSION: The NTCP for the rectum was almost consistent with the clinical frequency of late effects, whereas the NTCP for bladder was too high. To obtain reliable (SD of 12-13%) NTCP values, 3-4 CT scans are needed during 5-7 fractions of HDRB treatments.

Entities:  

Mesh:

Year:  2000        PMID: 10863066     DOI: 10.1016/s0360-3016(00)00510-1

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  10 in total

1.  A comparison of HDR brachytherapy and IMRT techniques for dose escalation in prostate cancer: a radiobiological modeling study.

Authors:  M Fatyga; J F Williamson; N Dogan; D Todor; J V Siebers; R George; I Barani; M Hagan
Journal:  Med Phys       Date:  2009-09       Impact factor: 4.071

2.  An integrated strategy of biological and physical constraints in biological optimization for cervical carcinoma.

Authors:  Ziwei Feng; Cheng Tao; Jian Zhu; Jinhu Chen; Gang Yu; Shaohua Qin; Yong Yin; Dengwang Li
Journal:  Radiat Oncol       Date:  2017-04-04       Impact factor: 3.481

3.  A treatment planning study comparing IMRT techniques and cyber knife for stereotactic body radiotherapy of low-risk prostate carcinoma.

Authors:  Sergiu Scobioala; Christopher Kittel; Khaled Elsayad; Kai Kroeger; Michael Oertel; Laith Samhouri; Uwe Haverkamp; Hans Theodor Eich
Journal:  Radiat Oncol       Date:  2019-08-09       Impact factor: 3.481

4.  Dosimetric feasibility of moderately hypofractionated/dose escalated radiation therapy for localised prostate cancer with intensity-modulated proton beam therapy using simultaneous integrated boost (SIB-IMPT) and impact of hydrogel prostate-rectum spacer.

Authors:  Dalia Ahmad Khalil; Danny Jazmati; Dirk Geismar; Jörg Wulff; Christian Bäumer; Paul Heinz Kramer; Theresa Steinmeier; Stefanie Schulze Schleitthoff; Sandija Plaude; Martin Bischoff; Stephan Tschirdewahn; Boris Hadaschik; Beate Timmermann
Journal:  Radiat Oncol       Date:  2022-04-01       Impact factor: 3.481

5.  Employing the therapeutic operating characteristic (TOC) graph for individualised dose prescription.

Authors:  Aswin L Hoffmann; Henk Huizenga; Johannes H A M Kaanders
Journal:  Radiat Oncol       Date:  2013-03-07       Impact factor: 3.481

6.  Better survival with three-dimensional conformal radiotherapy than with conventional radiotherapy for cervical cancer: a population-based study.

Authors:  Chen-Hsi Hsieh; Shiang-Jiun Tsai; Wen-Yen Chiou; Moon-Sing Lee; Hon-Yi Lin; Shih-Kai Hung
Journal:  ISRN Oncol       Date:  2013-10-02

7.  Investigation of whether in-room CT-based adaptive intracavitary brachytherapy for uterine cervical cancer is robust against interfractional location variations of organs and/or applicators.

Authors:  Yoshifumi Oku; Hidetaka Arimura; Tran Thi Thao Nguyen; Yoshiyuki Hiraki; Masahiko Toyota; Yasumasa Saigo; Takashi Yoshiura; Hideki Hirata
Journal:  J Radiat Res       Date:  2016-06-13       Impact factor: 2.724

8.  First clinical implementation of the Capri applicator.

Authors:  Aime M Gloi
Journal:  J Appl Clin Med Phys       Date:  2014-01-06       Impact factor: 2.102

9.  Prescription Value-Based Automatic Optimization of Importance Factors in Inverse Planning.

Authors:  Caiping Guo; Pengcheng Zhang; Zhiguo Gui; Huazhong Shu; Lihong Zhai; Jinrong Xu
Journal:  Technol Cancer Res Treat       Date:  2019 Jan-Dec

10.  Salvage reirradiation for local failure of prostate cancer after curative radiation therapy: Association of rectal toxicity with dose distribution and normal-tissue complication probability models.

Authors:  Giovanna Dipasquale; Thomas Zilli; Claudio Fiorino; Michel Rouzaud; Raymond Miralbell
Journal:  Adv Radiat Oncol       Date:  2018-06-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.